NovoCure Limited (NVCR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NovoCure Limited

    NASDAQ: NVCR · Real-Time Price · USD
    12.28
    0.30 (2.50%)
    At close: Sep 05, 2025, 3:59 PM
    12.45
    1.38%
    After-hours: Sep 05, 2025, 07:02 PM EDT

    NovoCure Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 605.22M 509.34M 537.84M 535.03M
    Cost of Revenue
    		 137.18M 128.28M 114.87M 114.88M
    Gross Profit
    		 468.04M 381.06M 422.97M 420.15M
    Operating Income
    		 -170.5M -232.87M -89.52M -44.33M
    Interest Income
    		 51M 46.04M 10.96M 791K
    Pretax Income
    		 -131.16M -191.74M -81.85M -52.08M
    Net Income
    		 -168.63M -207.04M -92.53M -58.35M
    Selling & General & Admin
    		 428.89M 390.87M 306.41M 263.18M
    Research & Development
    		 209.65M 223.06M 206.09M 201.3M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 638.53M 614.67M 512.5M 464.49M
    Interest Expense
    		 11.66M 4.91M 3.33M 3.44M
    Selling & Marketing Expenses
    		 239.06M 226.81M 173.66M 137.06M
    Cost & Expenses
    		 775.72M 742.21M 627.36M 579.36M
    Income Tax Expense
    		 37.47M 15.3M 10.69M 6.28M
    Shares Outstanding (Basic)
    		 107.83M 106.39M 104.66M 103.43M
    Shares Outstanding (Diluted)
    		 107.83M 106.39M 104.66M 103.43M
    EPS (Basic)
    		 -1.56 -1.95 -0.88 -0.56
    EPS (Diluted)
    		 -1.56 -1.95 -0.88 -0.56
    EBITDA
    		 -108.26M -175.87M -63.11M -38.38M
    EBIT
    		 -120.82M -188.42M -78.51M -48.63M
    Depreciation & Amortization
    		 11.23M 10.97M 10.62M 10.25M

    Add to Watchlist